Pharma Deals Review, Vol 2007, No 81 (2007)

Font Size:  Small  Medium  Large

VASTox Signs Drug Discovery Deals Worth a Combined US$1.3 M

Business Review Editor

Abstract


VASTox signed two deals worth a combined value of €1 M. VASTox formed a drug discovery and toxicology screening agreement with Rottapharm. In a deal with an unnamed European biotech, VASTox’s will support one of the client’s drug discovery programs.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.